I-SPY 2

Compliance Without Compromise: How to Ensure EHR Data Integrity
August 20, 2025

Compliance Without Compromise: How to Ensure EHR Data Integrity

At the AMIA Informatics Summit in 2025, researchers shared their promising EHR-to-EDC findings. They assessed five oncology trials across diverse...

Reading Time: 5 MinutesRead More
OpenClinica’s Most Read Blogs of 2025
July 23, 2025

OpenClinica’s Most Read Blogs of 2025

At OpenClinica, we publish a new blog most weeks. One of our favorite things to do is a mid-year checkup....

Reading Time: 3 MinutesRead More
Adaptive by Nature: Modern Tools for Modern Trial Designs
June 25, 2025

Adaptive by Nature: Modern Tools for Modern Trial Designs

Adaptive Platform Trials: Transforming Clinical Research with OpenClinica Adaptive platform trials (APTs) are transforming the way clinical research is conducted....

Reading Time: 4 MinutesRead More
EHR-to-EDC Success in a Complex Oncology, Adaptive Platform Trial
May 21, 2025

EHR-to-EDC Success in a Complex Oncology, Adaptive Platform Trial

At OpenClinica, we are especially proud of the work we are doing with the I-SPY 2 Trial, sponsored and operated...

Reading Time: 3 MinutesRead More
Case Study: I-SPY 2 Delivers Personalized Oncology Treatments Faster
April 29, 2025

Case Study: I-SPY 2 Delivers Personalized Oncology Treatments Faster

As we wrote in our new case study, The I-SPY series of trials are reshaping the future of personalized oncology...

Reading Time: 2 MinutesRead More
Oncology Clinical Trials Case Study: I-SPY 2 & OpenClinica
April 8, 2025

Oncology Clinical Trials Case Study: I-SPY 2 & OpenClinica

Without a doubt, oncology clinical trials are among the most complex and complicated trials. Two of the primary reasons are:...

Reading Time: 2 MinutesRead More

Marketing / Communications Opt-in

Which Solutions
would you like a quote for?